Sanara MedTech Inc. (NASDAQ: SMTI) reported Q2 EPS of ($0.41), $0.20 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $20.2 million versus the consensus estimate of $19.2 million.

For earnings history and earnings-related data on Sanara MedTech Inc. (SMTI) click here.